Amaç: Kalp hızı ve kan basıncı ölçümleri otonom sinir sistemi kontrolündeki kardiyovasküler düzenleyici mekanizmaların patofizyolojisi hakkın-da önemli veriler sağlarlar. Uyku apnesi gerek sempatik sinir sistemi aktivasyonu gerekse hipertansiyon ile ilişkili yeni bir kardiyovasküler risk faktörü olarak kabul edilmektedir. Bu çalışmada uyku apnesi ciddiyetinin gece kalp hızı değerleri üzerine etkisi ve gece kalp hızı değerlerinin hipertansiyon varlığı ile ilişkisi araştırıldı. Yöntemler: Hastanemizde gece kalp hızlarını da kaydeden polisomnografi cihazı ile uyku apnesi tanısı konulan tüm hastaların tıbbi kayıtları ve polisomnografik verileri retrospektif olarak değerlendirildi. Gece en düşük, ortalama ve en yüksek kalp hızları ile uyku apnesi alt gruplarındaki değişkenlik ve hipertansiyon varlığı arasındaki ilişki araştırıldı. Bulgular: Çalışmaya toplam 540 hasta alındı. Ciddi uyku apneli bireylerde, gece "ortalama" ve "en yüksek" kalp hızları, orta (sırasıyla, p=<0.049 ve p=0.044, erkeklerde; sırasıyla, p=0.002 ve P=NS, kadınlarda) ve hafif uyku apneli (sırasıyla, p=<0.001 ve p=0.004, erkeklerde; sırasıyla, p=<0.001 ve p=0.003, kadınlarda) olan gruplara göre istatistiki anlamlı olarak daha yüksekti. Yine gece ortalama kalp hızı ile apne hipopne indeksi (Pearson's p=0.504, p<0.001 kadınlarda; Pearson's p=0.254, p<0.001 erkeklerde) ve hipertansiyon varlığı (Spearman's p=0.090, p=0.394 kadınlar-da; Spearman's p=0.272, p<0.001 erkeklerde) arasında pozitif korelasyon mevcuttu. Sonuç: Bu çalışmada gece ortalama ve en yüksek kalp hızı değerlerinin uyku apnesi ciddiyeti ve hipertansiyon varlığı ile ilişkili olduğu saptandı. Uyku apneli hastalardaki artmış sempatik sinir sistemi aktivasyonuna bağlı artan ortalama ve en yüksek kalp hızlarının, uyku apnesi ve hipertansiyon varlığı arasındaki ilişkiyi açıklayan mekanizmalardan biri olabileceği ileri sürüldü. (Anadolu Kardiyol Derg 2011 Eyl 1; 11(6): 000-000) Anahtar kelimeler: Gece kalp hızı, uyku apnesi, hipertansiyon, sempatik sinir sistemi aktivasyonu ABSTRACT Objective: Both heart rate (HR) and blood pressure parameters provide important information on the pathophysiology of the cardiovascular regulatory mechanisms, and are mainly affected by the autonomic nervous system. We sought to clarify whether the severity of obstructive sleep apnea (OSA) affects nocturnal HRs and whether there is a relationship between nocturnal HRs and the presence of hypertension. Methods: We retrospectively reviewed medical records of all patients who performed nocturnal polysomnography with monitoring of HRs, and examined whether there is a relationship among the nocturnal HRs, the severity of OSA and the presence of hypertension. Results: A total of 540 patients were included in the study. Nocturnal mean and maximal HRs were significantly higher in severe OSA group than in moderate (p=0.002 and p>0.05 in females; p<0.049 and p=0.044, in males, respectively) and mild OSA groups (p<0.001 and p=0.003, respectively in females, p<0.001 and p=0.004, respectively in males); and there was a positive correlation between the nocturnal mean HR and apneahypopnea index (Pearson's p=0.504, p<0.001 in female group; Pearson's p=0.254, p<0.001 in male group) and again the nocturnal mean HR and the presence of HT (Spearman's p=0.090, p=0.394 in female group; Spearman's p=0.272, p<0.001 in male group) in both gender groups. Conclusion: We found that nocturnal mean and maximal HRs to be associated with severity of OSA and the presence of hypertension. We speculated that increased nocturnal mean and maximal HRs caused by sympathetic nervous system activation in OSA might be one of the mechanisms in explaining the hypertension and OSA association. (Anadolu Kardiyol Derg 2011 Sep 1; 11(6): 000-000)
Introduction
Obstructive sleep apnea (OSA) is the most common sleeprelated breathing disorder and is characterized by repetitive narrowing or collapse of the pharyngeal airway during sleep with decreases in oxygen saturation leading to a series of pathological events, primarily in the cardiovascular system (1) (2) (3) (4) . The mechanisms by which OSA affects the cardiovascular system may involve mechanical effects on intrathoracic pressure, sympathetic overstimulation, intermittent hypoxia, oxidative stress, inflammation, hyper coagulation, metabolic dysregulation and endothelial dysfunction (3, 5) . The repetitive respiratory events cause hypoxia, hypercapnea, arousals, or disrupted sleep singly or in combination (6) (7) (8) (9) (10) . These abnormal physiologic events result in increased sympathetic outflow and alterations in blood pressure control mechanisms. In particular, abnormal autonomic control and chronic sympathetic nervous system (SNS) activation appear to be key factors in the causal pathway linking OSA to cardiovascular disease (11) (12) (13) (14) .
It is well known that OSA is an independent risk factor for systemic hypertension (HT), however, the understanding of the pathogenic mechanisms linking both conditions is limited. It is probably multifactorial, with environmental, dietary, neural, humoral, mechanical and hemodynamic components and genetic inputs involved (15) (16) (17) (18) . The role that the autonomic nervous system plays in mediating these cardiovascular changes has been the focus of intensive research activity. One of the most important effects of OSA is an activation of SNS, which persists during the day and is thought to play a key role in the association of OSA and elevated systemic blood pressure (18, 19) .
Both heart rate (HR) and blood pressure parameters provide important information on the pathophysiology of the cardiovascular regulatory mechanisms, and are mainly affected by the autonomic nervous system with its sympathetic and parasympathetic components. Elevated HR is an important risk factor for cardiovascular disease (20, 21) . Previous studies, including large-scale cohort studies such as such the CASTEL and Framingham studies, have demonstrated a positive association between elevated HR at rest and adverse cardiovascular events in both the general population and the population with cardiovascular disease (22) (23) (24) (25) . There have been several reports on the results of spectral analysis of heart rate variability in OSA patients (26, 27) , but a few published on the HR of OSA (28) (29) (30) . Patients with OSA have found to have faster HRs during 24 hours, suggesting an increased cardiac sympathetic drive and the severity of OSA has been independently associated with increased mean HRs during 24 hours (29, 30) .
However, the association between the severity of OSA and nocturnal HR indices has not yet been fully investigated in patients with OSA.
Accordingly, we sought to clarify whether the severity of OSA affects nocturnal HRs and whether there is a relationship between nocturnal HRs and the presence of HT.
Methods

Study population
We retrospectively reviewed medical records of all patients who underwent nocturnal polysomnography (PSG) (Somnologica, Iceland) at Bayındır Hospital Sleep Disorders Center between January 2005 and January 2010.A total 864 patients had nocturnal PSG. Of them, 540 met the inclusion criteria. The ratio of male to female was about 1 to 5. Those patients who had the "first night effect", which is the alteration of the sleep structure in the unfamiliar environment of a sleep laboratory (31); those receiving drugs affecting cardiac conduction (such as beta blockers, dihydropyridines or verapamil) and those had inadequate or incomplete data were excluded from study.
Hypertension was defined as taking antihypertensive without regard to the actual measurement of blood pressure, or having a systolic blood pressure reading greater than 140 mm Hg or a diastolic blood pressure reading greater than 90 mm Hg (32) ; and the systolic and diastolic blood pressure measurements at the day of PSG were recorded.
Polysomnography
The international standard for reading PSG results was used for the sleep stages and events (33, 34) .
Nocturnal HRs was recorded as mean, minimal and maximal HRs during sleep by PSG. The OSA is accepted when a patient has a total apnea-hypopnea index (AHI; number of apneas and hypopneas per hour of sleep) ≥5 and symptoms of excessive daytime sleepiness; and severity of OSA were categorized into three groups according to the AHI: AHI <15/h (mild OSA group), AHI <30/h (moderate OSA group), and AHI ≥30/h (severe OSA group) (33, 34) .
Statistical analysis
The SPSS statistical software package (version 16.0; SPSS Inc, Chicago, Ill, USA) was used to perform all statistical calculations. Continuous variables were expressed as mean±SD. The independent samples t-test or Mann-Whitney U test were used to compare continuous variables, when appropriate according to normality test results. Categorical variables were expressed as numbers and percentages, and compared using the Chisquare test. Since the frequency and severity of OSA are greater in men than women (35, 36) , all comparisons were made separately for both genders by two steps. First, we compared the basal clinical and polysmonographic data between the men and women using independent sample t-test. Second, the analysis of variance (ANOVA) with post hoc Tukey's HSD test was used for the statistical analysis of the results. Relationships between the continuous variables were evaluated by Pearson's correlation analysis when data were normally distributed or by Spearman's correlation analysis when they were not normally distributed. For all tests, a value of p <0.05 was considered significant.
Results
Since there were significant differences including age and body mass index between the both gender groups (p<0.001); all comparisons were made separately (Table 1) .
In comparison of groups regarding severity of OSA, there was statistically important difference in nocturnal mean HR (p<0.001 for both genders), maximal HR (p=0.004 in females; p=0.003 in males), the presence of HT (p=0.026 in females, p<0.001 in males) and systolic (p=0.004 in females, p<0.001 in males) and diastolic (p=NS in females; p<0.001 in males) blood pressure among OSA subgroups in both gender groups ( Table 2) .
Nocturnal mean and maximal HRs were significantly highest in severe OSA group (Table 2 ). For HT, systolic and diastolic blood pressures, and maximal and mean HRs, we also performed a post hoc Tukey test to evaluate intergroup differences in detail, and found a statistically significant difference as regard mean HR among all OSA subgroups in males; but not only between the mild and moderate OSA groups in females ( Table 3) .
The Spearman correlation analyses showed a significant positive correlation between the nocturnal mean HR and AHI in both gender groups (Pearson's p=0.504, p<0.001 in female group; Pearson's p=0.254, p<0.001 in male group), and between the nocturnal mean HR and HT in males but not females (Spearman's p=0.090, p=0.394 in female group; Spearman's p=0.272, p<0.001 in male group).
Discussion
In the presented study, nocturnal mean and maximal but not minimal HRs found to be well correlated with AHI and the presence of HT in patients with OSA. Our findings suggested that increased nocturnal sympathetic activation determined by nocturnal mean and maximal HRs may be responsible for one of the mechanisms in explaining the HT and OSA association.
There have been few reports on the association of HRs and OSA (28) (29) (30) . Whereas some of them have reported no difference in the HRs between patients with OSA and normal controls, and no difference in the HR among OSA patients before and with nocturnal continuous positive airway pressure (nCPAP) treatment (27, 28) ; the others reported that the severity of OSA has been independently associated with increased mean HRs during 24 hour and the favorable effect of nCPAP on HR indices in patients with OSA (29, 30) . These conflicting results may have been obtained due to the characteristic pattern of bradycardia and tachycardia during sleep in OSA patients.
In presented study, mean and maximal HRs were correlated with the OSA severity. This elevation in mean HR in patients with OSA has been thought to be due to activated sympathetic nervous system (SNS). Brief episodes of apnea/hypopnea increase SNS activation by suspending the tonic inhibition of sympathetic outflow by pulmonary stretch receptors (37) and by the stimulation of peripheral and central chemoreceptor (14, 38) . The SNS is activated even during wakefulness in patients with OSA (13, 39) . The mechanisms for the activation of the SNS during 24 hour are not fully understood, but one possibility is that increased chemoreflex gain by OSA results in tonic chemoreflex activation even during normoxia, with consequent increased sympathetic activity (26) . Effective treatment of OSA by CPAP has been shown to markedly and acutely decrease BP and the mean HR throughout the Data are presented as mean±SD and number (percentage) *Unpaired Student's t-test and Chi-square test AHI -apnea hypopnea index, AI -apnea index, BMI -body mass index, bpm-beats per minute, DBP -diastolic blood pressure, HR -heart rate, HI -hypopnea index, LM -leg movements, LSSP -left side sleeping position, ODI -oxygen desaturation event index, PLM -periodic leg movements, RSSP -right side sleeping position, SP -supine position, SBP -systolic blood pressure Table 1 . Basal demographic, clinical characteristics and polysomnographic results according to gender day, suggesting a possible improvement cardiovascular consequences in short and long term after the NCPAP therapy probably by restoration of SNS (13, 30) . The elimination of tonic chemoreflex drive by administration 100% oxygen in OSA significantly lowers sympathetic activity and resting HR during wakefulness, suggesting that the activation of the SNS contributes mainly to elevated HR and blood pressure in patients with OSA (13, 40) . These data are also in agreement with the other clinical studies reporting beta blockers (atenolol) has been shown to reduce the nocturnal pressure slightly more than the other drugs, although there is no current evidence that any specific antihypertensive drug has direct effects on attenuating sleep apnea severity (41) . Similar to this finding, it has been showed that also the BP increase can be attenuated by pharmacological blockade of the autonomic nervous system with hexamethonium, indicating that it is mediated by the SNS rather than by mechanical factors related to changes in intrathoracic pressure. Somers et al. (15) proposed baroreflex impairment, mainly found in patients with arterial HT, to be susceptible for excessive autonomic response in patients with OSA, which has been proposed as an independent risk factor for the development of essential HT (1, 2, 42) .
Study limitations
The main limitation of the present study resides in its retrospective design. Secondly, there was a relatively small sample size in female group. Thirdly; the relationship between sleep apnea severity and hypertension was based on office blood pressure measurements made once on the PSG day. However, it is well known in that morning and evening blood pressure measurements may differ and sleep apnea patients even demonstrate much higher blood pressure levels during sleep. The paper is not powered enough to address this relationship. 
Conclusion
In presented study, we found that nocturnal mean and maximal HRs to be associated with severity of OSA and the presence of HT. Patients with OSA experience significant physiologic stress at night, in which low oxygen levels activate the SNS, which may also contribute to elevation of blood pressure and heart rate. Considered together, we believe that increased nocturnal mean and maximal HRs caused by SNS activation in OSA might be one of the mechanism in explaining the hypertension and OSA association. 
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